746
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors

, , , , , & show all
Pages 42-49 | Received 01 Apr 2010, Accepted 01 Nov 2010, Published online: 01 Feb 2011

  • Almeida Matos M. The role of protein C deficiency in the etiology of Perthes disease. Ortop Traumatol Rehabil 2008; 10(3):274-8.
  • Asano T, Takahashi KA, Fujioka M, Inoue S, Ueshima K, Hirata T, Okamoto M, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo T. Relationship between postrenal transplant osteonecrosis of the femoral head and gene polymorphisms related to the coagulation and fibrinolytic systems in Japanese subjects. Transplantation 2004; 77(2):220-5.
  • Aso Y. Plasminogen activator inhibitor (PAI)-1 in vascular inflammation and thrombosis. Front Biosci 2007; 12:2957-66.
  • Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 2002; 32(2):94-124.
  • Benowitz NL, Fitzgerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function—comparison of transdermal nicotine and cigarette-smoking. J Am Coll Cardiol 1993; 22(4):1159-67.
  • Björkman A, Svensson PJ, Hillarp A, Burtscher IM, Rünow A, Benoni G. Factor V Leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. Clin Orthop 2004; (425):168-72.
  • Brotman DJ, Girod JP, Posch A, Jani JT, Patel JV, Gupta M, Lip GY, Reddy S, Kickler TS. Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers. Thromb Res 2006; 118(2):247-52.
  • Glueck CJ, Freiberg RA, Crawford A, Gruppo R, Roy D, Tracy T, Sieve-Smith L, Wang P. Secondhand smoke, hypofibrinolysis, and Legg-Perthes disease. Clin Orthop 1998; (352):159-67.
  • Glueck CJ, Fontaine RN, Gruppo R, Stroop D, Sieve-Smith L, Tracy T, Wang P. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. Clin Orthop 1999; (366):133-46.
  • Glueck CJ, Freiberg RA, Wang P. Role of thrombosis in osteonecrosis. Curr Hematol Rep 2003; 2(5):417-22.
  • Halleux CM, Declerck PJ, Tran SL, Detry R, Brichard SM. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. J Clin Endocrinol Metab 1999; 84(11):4097-105.
  • Kaplan KL. Proteins secreted by platelets: significance in detecting thrombosis. Adv Exp Med Biol 1978; 102:105-19.
  • Kerachian MA, Séguin C, Harvey EJ. Glucocorticoids in osteonecrosis of the femoral head: a new understanding of the mechanisms of action. J Steroid Biochem Mol Biol 2009; 114(3-5):121-8.
  • Koo KH, Song HR, Ha YC, Kim JR, Kim SJ, Kim KI, Chang KC, Ahn IO, Cho SH. Role of thrombotic and fibrinolytic disorders in the etiology of Perthes' disease. Clin Orthop 2002; (399):162-7.
  • Kruithof EK. Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost 2008; 100(6):969-75.
  • Kuo BS, Dryjski M, Bjornsson TD. Influence of nicotine and cotinine on the expression of plasminogen activator activity in bovine aortic endothelial cells. Thromb Haemost 1989; 61(1):70-6.
  • Lee JS, Koo KH, Ha YC, Koh KK, Kim SJ, Kim JR, Song HR, Cho SH. Role of thrombotic and fibrinolytic disorders in osteonecrosis of the femoral head. Clin Orthop 2003; (417):270-6.
  • Lijnen HR. Obesity and vascular risk. Hamostaseologie 2009; 29(1):44-5.
  • Marx RE. Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws. J Oral Maxillofac Surg (5 Suppl) 2009; 67:107-19.
  • Mehsen N, Barnetche T, Redonnet-Vernhet I, Guérin V, Bentaberry F, Gonnet-Gracia C, Schaeverbeke T. Coagulopathies frequency in aseptic osteonecrosis patients. Joint Bone Spine 2009; 76(2):166-9.
  • Mehta JS, Conybeare ME, Hinves BL, Winter JB. Protein C levels in patients with Legg-Calve-Perthes disease: is it a true deficiency? J Pediatr Orthop 2006; 26 (2): 200-3.
  • Min BW, Song KS, Cho CH, Lee SM, Lee KJ. Untreated asymptomatic hips in patients with osteonecrosis of the femoral head. Clin Orthop 2008; (466) (5): 1087-92.
  • Mont MA, Jones LC, Seyler TM, Marulanda GA, Saleh KJ, Delanois RE. New treatment approaches for osteonecrosis of the femoral head: an overview. Instr Course Lect 2007; 56:197-212.
  • Pósán E, Szepesi K, Gáspár L, Csernátony Z, Hársfalvi J, Ajzner E, Tóth A, Udvardy M. Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. Blood Coagul Fibrinolysis 2003; 14(3):243-8.
  • Rabquer BJ, Tan GJ, Shaheen PJ, Haines GK 3rd, Urquhart AG, Koch AE. Synovial inflammation in patients with osteonecrosis of the femoral head. Clin Transl Sci 2009; 2(4):273-8.
  • Sakaguchi M, Tanaka T, Fukushima W, Kubo T, Hirota Y. Impact of oral corticosteroid use for idiopathic osteonecrosis of the femoral head: a nationwide multicenter case-control study in Japan. J Orthop Sci 2010; 15(2):185-91.
  • Salgado A, Bóveda JL, Monasterio J, Segura RM, Mourelle M, Gómez-Jiménez J, Peracaula R. Inflammatory mediators and their influence on haemostasis. Haemostasis 1994; 24(2):132-8.
  • Séguin C, Kassis J, Busque L, Bestawros A, Theodoropoulos J, Alonso ML, Harvey EJ. Non-traumatic necrosis of bone (osteonecrosis) is associated with endothelial cell activation but not thrombophilia. Rheumatology (Oxford) 2008; 47(8):1151-5.
  • Sugano N, Atsumi T, Ohzono K, Kubo T, Hotokebuchi T, Takaoka K. The 2001 revised criteria for diagnosis, classification, and staging of idiopathic osteonecrosis of the femoral head. J Orthop Sci 2002; 7(5):601-5.
  • Tapson VF. The role of smoking in coagulation and thromboembolism in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2(1):71-7.
  • Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH. Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 2005; 26(17):1765-73.
  • Winniford MD, Jansen DE, Reynolds GA, Apprill P, Black WH, Hillis LD. Cigarette smoking-induced coronary vasoconstriction in atherosclerotic coronary artery disease and prevention by calcium antagonists and nitroglycerin. Am J Cardiol 1987; 59(4):203-7.
  • Wu X, Yang S, Duan D, Zhang Y, Wang J. Experimental osteonecrosis induced by a combination of low-dose lipopolysaccharide and high-dose methylprednisolone in rabbits. Joint Bone Spine 2008; 75(5):573-8.
  • Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007; 131(5):1557-66.
  • Yokota K, Ishida O, Sunagawa T, Suzuki O, Nakamae A, Ochi M. Platelet-rich plasma accelerated surgical angiogenesis in vascular-implanted necrotic bone: an experimental study in rabbits. Acta Orthop 2008; 79(1):106-10.
  • Zalavras C, Dailiana Z, Elisaf M, Bairaktari E, Vlachogiannopoulos P, Katsaraki A, Malizos KN. Potential aetiological factors concerning the development of osteonecrosis of the femoral head. Eur J Clin Invest 2000; 30(3):215-21.
  • Zidovetzki R, Chen P, Fisher M, Hofman FM, Faraci FM. Nicotine increases plasminogen activator inhibitor-1 production by human brain endothelial cells via protein kinase C-associated pathway. Stroke 1999; 30(3):651-5.
  • Zimmermann R, Arnold D, Strasser E, Ringwald J, Schlegel A, Wiltfang J, Eckstein R. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates. Vox Sang 2003; 85(4):283-9.